GE HealthCare Technologies (NASDAQ:GEHC) Issues FY 2025 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 4.610-4.750 for the period, compared to the consensus EPS estimate of 4.650. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

A number of brokerages have commented on GEHC. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.77.

GE HealthCare Technologies Stock Up 9.2 %

Shares of GE HealthCare Technologies stock traded up $7.90 on Thursday, reaching $93.80. The stock had a trading volume of 4,835,954 shares, compared to its average volume of 2,714,813. The company has a 50 day moving average price of $83.58 and a 200 day moving average price of $85.39. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies has a 1 year low of $74.51 and a 1 year high of $94.80. The stock has a market capitalization of $42.85 billion, a P/E ratio of 25.85, a P/E/G ratio of 2.93 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. As a group, equities research analysts forecast that GE HealthCare Technologies will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.15%. The ex-dividend date is Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is currently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.